Nocteva is a Norwegian biotechnology company providing multi-omics, bioinformatics, and human disease modeling services for biomedical research and drug development.

Our services include single-cell and single-nucleus RNA sequencing, bulk RNA sequencing, proteomics, advanced microscopy and image analysis, and bioinformatics. Customers can access these services individually or as part of larger research projects, from sample processing and data generation to advanced analysis.

Beyond molecular profiling, Nocteva provides an end-to-end preclinical research platform spanning iPSC generation, genome engineering, human and patient-derived organoid models, disease characterization, drug screening, and functional testing.

Built on more than 30 years of research experience, we combine molecular profiling with human-relevant disease models to investigate disease mechanisms, identify potential therapeutic targets, and evaluate drug candidates. We make advanced technologies and model systems accessible to researchers and companies working to develop new treatments."